Loading...
XNYS
ZBH
Market cap18bUSD
Dec 05, Last price  
94.28USD
1D
1.20%
1Q
-10.83%
Jan 2017
-8.64%
IPO
235.52%
Name

Zimmer Biomet Holdings Inc

Chart & Performance

D1W1MN
XNYS:ZBH chart
P/E
20.67
P/S
2.43
EPS
4.56
Div Yield, %
0.76%
Shrs. gr., 5y
-0.27%
Rev. gr., 5y
-0.77%
Revenues
7.68b
+3.85%
3,286,100,0003,495,400,0003,897,500,0004,121,100,0004,095,400,0004,220,200,0004,451,800,0004,471,700,0004,623,400,0004,673,300,0005,997,800,0007,683,900,0007,824,100,0007,932,900,0007,982,200,0007,024,500,0006,827,300,0006,939,900,0007,394,200,0007,678,600,000
Net income
904m
-11.74%
732,500,000834,500,000773,200,000848,600,000717,400,000596,900,000760,800,000755,000,000761,000,000720,100,00049,700,000302,900,0001,839,600,000-379,200,0001,131,600,000-137,400,000401,600,000231,400,0001,024,000,000903,800,000
CFO
1.50b
-5.20%
878,200,0001,040,700,0001,084,400,0001,038,100,0001,117,500,0001,193,500,0001,176,900,0001,151,900,000963,100,0001,052,800,000862,800,0001,632,200,0001,582,300,0001,747,400,0001,585,800,0001,204,500,0001,499,200,0001,284,700,0001,581,600,0001,499,400,000
Dividend
Sep 30, 20240.24 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Zimmer Biomet Holdings, Inc. provides musculoskeletal healthcare services. The company is headquartered in Warsaw Indiana, Indiana and currently employs 19,000 full-time employees. The firm's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The firm manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The firm's product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
URL
https://www.zimmerbiomet.com/en
IPO date
Jul 25, 2001
Employees
18,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT